The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
about
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.A Macroscopic Mathematical Model for Cell Migration Assays Using a Real-Time Cell AnalysisUrokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines.Annexin A1 Treatment Improves Skin Heterologous Transplantation by Modulating Inflammation and Angiogenesis Processes
P2860
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The urokinase receptor-derived ...... coma and chondrosarcoma cells.
@en
The urokinase receptor-derived ...... coma and chondrosarcoma cells.
@nl
type
label
The urokinase receptor-derived ...... coma and chondrosarcoma cells.
@en
The urokinase receptor-derived ...... coma and chondrosarcoma cells.
@nl
prefLabel
The urokinase receptor-derived ...... coma and chondrosarcoma cells.
@en
The urokinase receptor-derived ...... coma and chondrosarcoma cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
The urokinase receptor-derived ...... rcoma and chondrosarcoma cells
@en
P2093
Ali Munaim Yousif
Annarosaria De Chiara
Flavio Fazioli
Katia Bifulco
Maria Letizia Motti
Michele Gallo
Paolo Grieco
P2860
P304
54474-54487
P356
10.18632/ONCOTARGET.9976
P407
P50
P577
2016-08-01T00:00:00Z